1,1'-METHYLENEDIPIPERIDINE
General Information
Mainterm | 1,1'-METHYLENEDIPIPERIDINE |
CAS Reg.No.(or other ID) | 880-09-1 |
Regnum |
175.105 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 70151 |
IUPAC Name | 1-(piperidin-1-ylmethyl)piperidine |
InChI | InChI=1S/C11H22N2/c1-3-7-12(8-4-1)11-13-9-5-2-6-10-13/h1-11H2 |
InChI Key | LRKYLKBLUJXTFL-UHFFFAOYSA-N |
Canonical SMILES | C1CCN(CC1)CN2CCCCC2 |
Molecular Formula | C11H22N2 |
Wikipedia | dipiperidinomethane |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 182.311 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Complexity | 119.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B z A A A A A A A A A A A A A A A A A A A A A A A A A A A s W A A A A A A A A A A A A A A A H A A A A A A A C A D B A A Q B A A M A A A A A A A A A A A A A A A A A A A A A A A A I A A C A A A I A g A A E A A A I A A K A A A A Q A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 6.5 |
Monoisotopic Mass | 182.178 |
Exact Mass | 182.178 |
XLogP3 | None |
XLogP3-AA | 2.1 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 13 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9675 |
Human Intestinal Absorption | HIA+ | 0.7543 |
Caco-2 Permeability | Caco2+ | 0.6393 |
P-glycoprotein Substrate | Substrate | 0.5550 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6675 |
Non-inhibitor | 0.7933 | |
Renal Organic Cation Transporter | Inhibitor | 0.8057 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7081 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8827 |
CYP450 2D6 Substrate | Substrate | 0.6472 |
CYP450 3A4 Substrate | Non-substrate | 0.7662 |
CYP450 1A2 Inhibitor | Inhibitor | 0.5347 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9359 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9358 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8583 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9138 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5506 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.6927 |
Non-inhibitor | 0.5637 | |
AMES Toxicity | Non AMES toxic | 0.5710 |
Carcinogens | Non-carcinogens | 0.9421 |
Fish Toxicity | Low FHMT | 0.8859 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8250 |
Honey Bee Toxicity | Low HBT | 0.7747 |
Biodegradation | Not ready biodegradable | 0.7358 |
Acute Oral Toxicity | III | 0.6052 |
Carcinogenicity (Three-class) | Non-required | 0.5856 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.6906 | LogS |
Caco-2 Permeability | 1.2140 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.7121 | LD50, mol/kg |
Fish Toxicity | 3.4283 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.3591 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organoheterocyclic compounds |
Class | Piperidines |
Subclass | Not available |
Intermediate Tree Nodes | Not available |
Direct Parent | Piperidines |
Alternative Parents | |
Molecular Framework | Aliphatic heteromonocyclic compounds |
Substituents | Piperidine - Azacycle - Aminal - Organic nitrogen compound - Organopnictogen compound - Hydrocarbon derivative - Organonitrogen compound - Aliphatic heteromonocyclic compound |
Description | This compound belongs to the class of organic compounds known as piperidines. These are compounds containing a piperidine ring, which is a saturated aliphatic six-member ring with one nitrogen atom and five carbon atoms. |
From ClassyFire